GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation
- PMID: 19576181
- DOI: 10.1016/j.bcp.2009.06.096
GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation
Abstract
The vagus nerve can limit inflammation via the alpha7 nicotinic acetylcholine receptor (alpha7nAChR). Selective pharmacological stimulation of the alpha7nAChR may have therapeutic potential for the treatment of inflammatory conditions. We determined the anti-inflammatory potential of GTS-21, an alpha7nAChR-selective partial agonist, on primary human leukocytes and compared it with nicotine, the nAChR agonist widely used for research into the anti-inflammatory effects of alpha7nAChR stimulation. Furthermore, we investigated whether the effects of both nicotinic agonists were restricted to specific Toll-like receptors (TLRs) stimulated and explored the mechanism behind the anti-inflammatory effect of GTS-21. GTS-21 and nicotine inhibited the release of pro-inflammatory cytokines in peripheral blood mononuclear cells (PBMCs), monocytes and whole blood independent of the TLR stimulated, with higher potency/efficacy for GTS-21 compared to nicotine. The anti-inflammatory cytokine IL-10 was relatively unaffected by both nicotinic agonists. The effects of GTS-21 and nicotine could not be reversed by nAChR antagonists, while the JAK2 inhibitor AG490 abolished the anti-inflammatory effects. GTS-21 downregulated monocyte cell-surface expression of TLR2, TLR4 and CD14. qPCR analysis demonstrated that the anti-inflammatory effect of GTS-21 is mediated at the transcriptional level and involves JAK2-STAT3 activation. In conclusion, GTS-21 has a profound anti-inflammatory effect in human leukocytes and that GTS-21 is more potent/efficacious than nicotine. The absence of a blocking effect of nAChR antagonists in human leukocytes might indicate different pharmacological properties of the alpha7nAChR in human leukocytes compared to other cell types. GTS-21 may be promising from a therapeutic perspective because of its suitability for human use.
Similar articles
-
The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia.J Neuroimmunol. 2012 Oct 15;251(1-2):65-72. doi: 10.1016/j.jneuroim.2012.07.006. Epub 2012 Aug 9. J Neuroimmunol. 2012. PMID: 22884467
-
Effects of the α7 nicotinic acetylcholine receptor agonist GTS-21 on the innate immune response in humans.Shock. 2011 Jul;36(1):5-11. doi: 10.1097/SHK.0b013e3182168d56. Shock. 2011. PMID: 21368716 Clinical Trial.
-
Stimulation of alpha 7 cholinergic receptors inhibits lipopolysaccharide-induced neutrophil recruitment by a tumor necrosis factor alpha-independent mechanism.Shock. 2007 Apr;27(4):443-7. doi: 10.1097/01.shk.0000245016.78493.bb. Shock. 2007. PMID: 17414429
-
The vagus nerve and the nicotinic anti-inflammatory pathway.Nat Rev Drug Discov. 2005 Aug;4(8):673-84. doi: 10.1038/nrd1797. Nat Rev Drug Discov. 2005. PMID: 16056392 Review.
-
Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation.J Neuroimmune Pharmacol. 2015 Sep;10(3):468-76. doi: 10.1007/s11481-015-9601-5. Epub 2015 Apr 14. J Neuroimmune Pharmacol. 2015. PMID: 25870122 Free PMC article. Review.
Cited by
-
The vagal innervation of the gut and immune homeostasis.Gut. 2013 Aug;62(8):1214-22. doi: 10.1136/gutjnl-2012-302550. Epub 2012 Sep 29. Gut. 2013. PMID: 23023166 Free PMC article. Review.
-
Targeting the "cytokine storm" for therapeutic benefit.Clin Vaccine Immunol. 2013 Mar;20(3):319-27. doi: 10.1128/CVI.00636-12. Epub 2013 Jan 2. Clin Vaccine Immunol. 2013. PMID: 23283640 Free PMC article. Review.
-
Cholinergic Signaling Attenuates Pro-Inflammatory Interleukin-8 Response in Colonic Epithelial Cells.Front Immunol. 2022 Jan 6;12:781147. doi: 10.3389/fimmu.2021.781147. eCollection 2021. Front Immunol. 2022. PMID: 35069554 Free PMC article. Clinical Trial.
-
The Protective Effect of Alpha 7 Nicotinic Acetylcholine Receptor Activation on Critical Illness and Its Mechanism.Int J Biol Sci. 2017 Jan 1;13(1):46-56. doi: 10.7150/ijbs.16404. eCollection 2017. Int J Biol Sci. 2017. PMID: 28123345 Free PMC article. Review.
-
NS6740, an α7 nicotinic acetylcholine receptor silent agonist, disrupts hippocampal synaptic plasticity.Neurosci Lett. 2018 Jun 11;677:6-13. doi: 10.1016/j.neulet.2018.04.025. Epub 2018 Apr 19. Neurosci Lett. 2018. PMID: 29679680 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous